What is the Emcure Pharmaceuticals Ltd share price today?

The share price of NSE:EMCURE-EQ on 01 Oct 2026 (as of 15:03:28 IST) is ₹1941.9.

What is the NSE:EMCURE-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:EMCURE-EQ 52 week high low range shows a high of ₹2100.7 and a low of ₹1260.

What is the Emcure Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Emcure Pharmaceuticals Ltd market cap is ₹368456000000.

What is the shareholding pattern of Emcure Pharmaceuticals Ltd Stock?

The shareholding pattern of Emcure Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 77.83% Foreign Institutional Investors (FII): 4.87% Domestic Institutional Investors (DII): 1.59% Mutual Funds: 6.87% Retail & Others: 8.84% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Emcure Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Emcure Pharmaceuticals Ltd is 36.4307, and the Price-to-Book (PB) ratio is 6.1275, as on 01 Oct 2026.

Emcure Pharmaceuticals Share Price

2174.20+197.60 (+10.00%)

+63.97% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+10.00%

1 Week

+16.16%

1 Month

+12.24%

3 Month

+12.26%

6 Month

+32.33%

YTD

+59.34%

1 Year

+63.97%

5 Year

10 Year

Max

+64.08%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

2035.10

1853.60

1716.00

1636.10

1306.50

High

2174.20

About

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

EMCURENSE

LTP

1W Low

1W High

Market cap (₹)

1789.4+11.7 (0.66%)

1722

1810.40

4,25,150Cr

10031+251 (2.57%)

9863

10067

2,66,265Cr

4672.4+59 (1.28%)

4553

4685.60

1,76,301Cr

2330-75.5 (-3.14%)

2252.40

2441.90

1,25,352Cr

1259.5+14 (1.12%)

1217.20

1266.60

1,23,591Cr

1370.3+18.3 (1.35%)

1336.70

1376.70

1,14,351Cr

1398+19.1 (1.39%)

1364.60

1400.80

1,12,474Cr

2488.7-4.1 (-0.16%)

2457.90

2512.30

1,02,315Cr

1704.3+22.9 (1.36%)

1656.20

1713.80

97,757Cr

2045.4+34.4 (1.71%)

1988.90

2062.10

92,007Cr

2174.2+302.4 (16.16%)

1853.60

2174.20

37,611Cr

Emcure Pharmaceuticals Share Price

2174.20+197.60 (+10.00%)

+63.97% past 1 Year

Financial overview

Compounded Sales Growth

10 years8%

5 years9%

3 years15%

Last year17%

Compounded Profit Growth

10 years5%

5 years19%

3 years20%

Last year33%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year49%

Return on Equity

10 years18%

5 years23%

3 years20%

Last year20%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
8%	9%	15%	17%
5%	19%	20%	33%
-	-	-	49%
18%	23%	20%	20%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

EMCURE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,789.4	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
10,031	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,672.4	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,330	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,259.5	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,370.3	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,398.1	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,488.7	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,704.3	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,045.4	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
2,174.2	₹37611 Cr	34.4	17.16	80.31	₹924 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
₹2820 Cr	₹2580 Cr	₹2470 Cr	₹2363 Cr	₹2270 Cr	₹2101 Cr	₹2116 Cr	₹1963 Cr	₹2002 Cr	₹1815 Cr	₹1771 Cr	₹1668 Cr	₹1663 Cr	₹1556 Cr
₹3 Cr	₹2 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹36 Cr	₹23 Cr	₹12 Cr	₹16 Cr	₹1 Cr	₹15 Cr
₹2824 Cr	₹2583 Cr	₹2474 Cr	₹2365 Cr	₹2273 Cr	₹2104 Cr	₹2121 Cr	₹1967 Cr	₹2038 Cr	₹1838 Cr	₹1784 Cr	₹1683 Cr	₹1664 Cr	₹1571 Cr
₹2342 Cr	₹2157 Cr	₹2096 Cr	₹1975 Cr	₹1899 Cr	₹1783 Cr	₹1811 Cr	₹1705 Cr	₹1718 Cr	₹1572 Cr	₹1551 Cr	₹1445 Cr	₹1404 Cr	₹1328 Cr
₹591 Cr	₹535 Cr	₹484 Cr	₹495 Cr	₹479 Cr	₹420 Cr	₹407 Cr	₹359 Cr	₹417 Cr	₹360 Cr	₹323 Cr	₹323 Cr	₹330 Cr	₹311 Cr
₹36 Cr	₹32 Cr	₹46 Cr	₹38 Cr	₹33 Cr	₹27 Cr	₹39 Cr	₹32 Cr	₹46 Cr	₹59 Cr	₹65 Cr	₹61 Cr	₹59 Cr	₹52 Cr
₹446 Cr	₹394 Cr	₹341 Cr	₹314 Cr	₹341 Cr	₹291 Cr	₹261 Cr	₹230 Cr	₹273 Cr	₹207 Cr	₹167 Cr	₹171 Cr	₹198 Cr	₹191 Cr
₹325 Cr	₹292 Cr	₹244 Cr	₹231 Cr	₹251 Cr	₹215 Cr	₹197 Cr	₹156 Cr	₹202 Cr	₹153 Cr	₹121 Cr	₹120 Cr	₹146 Cr	₹141 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Less Impairment of Assets

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹190 Cr	₹189 Cr	₹181 Cr	₹181 Cr	₹181 Cr	₹181 Cr	₹181 Cr	₹181 Cr	₹181 Cr	₹181 Cr	₹181 Cr	₹45 Cr	₹35 Cr	₹49 Cr	₹49 Cr	₹49 Cr
₹12 Cr	₹12 Cr	₹14 Cr	₹15 Cr	₹16 Cr	₹12 Cr	₹27 Cr	₹15 Cr	₹16 Cr	₹14 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0
₹4748 Cr	₹4245 Cr	₹2757 Cr	₹2305 Cr	₹1791 Cr	₹2080 Cr	₹1704 Cr	₹1639 Cr	₹1504 Cr	₹1387 Cr	₹1202 Cr	₹922 Cr	₹402 Cr	₹319 Cr	₹136 Cr	₹280 Cr
₹4748 Cr	₹4245 Cr	₹2757 Cr	₹2305 Cr	₹1791 Cr	₹2080 Cr	₹1704 Cr	₹1639 Cr	₹1504 Cr	₹1378 Cr	₹1194 Cr	₹913 Cr	₹402 Cr	₹319 Cr	₹136 Cr	₹280 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹8 Cr	₹8 Cr	₹8 Cr	₹6 L	₹8 L	₹10 L	₹12 L
₹4950 Cr	₹4446 Cr	₹2952 Cr	₹2501 Cr	₹1988 Cr	₹2273 Cr	₹1912 Cr	₹1835 Cr	₹1701 Cr	₹1582 Cr	₹1393 Cr	₹967 Cr	₹437 Cr	₹368 Cr	₹185 Cr	₹329 Cr
₹27 Cr	₹195 Cr	₹169 Cr	₹149 Cr	₹127 Cr	₹95 Cr	₹72 Cr	₹65 Cr	₹54 Cr	₹67 Cr	₹61 Cr	₹47 Cr	₹14 Cr	₹10 Cr	₹9 Cr	₹7 Cr
₹250 Cr	₹186 Cr	₹761 Cr	₹737 Cr	₹709 Cr	₹694 Cr	₹541 Cr	₹674 Cr	₹790 Cr	₹951 Cr	₹910 Cr	₹381 Cr	₹311 Cr	₹165 Cr	₹153 Cr	₹148 Cr
₹2 Cr	₹4 Cr	₹5 Cr	₹7 Cr	₹9 Cr	₹10 Cr	₹12 Cr	₹14 Cr	₹15 Cr	₹19 Cr	₹18 Cr	₹13 Cr	₹3 Cr	₹0	₹0	₹0
-₹41 Cr	₹9 Cr	₹41 Cr	-₹60 Cr	-₹73 Cr	-₹108 Cr	-₹157 Cr	-₹137 Cr	-₹155 Cr	-₹170 Cr	-₹147 Cr	₹22 Cr	₹32 Cr	₹13 Cr	-₹67 Cr	₹16 Cr
₹331 Cr	₹565 Cr	₹527 Cr	₹181 Cr	₹182 Cr	₹221 Cr	₹444 Cr	₹390 Cr	₹299 Cr	₹271 Cr	₹260 Cr	₹44 Cr	₹93 Cr	₹22 Cr	₹23 Cr	₹19 Cr
₹43 Cr	₹48 Cr	₹43 Cr	₹40 Cr	₹42 Cr	₹66 Cr	₹58 Cr	₹56 Cr	₹48 Cr	₹56 Cr	₹16 Cr	₹73 Cr	₹13 Cr	₹94 Cr	₹256 Cr	₹8 Cr
₹584 Cr	₹812 Cr	₹1377 Cr	₹905 Cr	₹868 Cr	₹883 Cr	₹899 Cr	₹997 Cr	₹998 Cr	₹1126 Cr	₹1057 Cr	₹534 Cr	₹451 Cr	₹294 Cr	₹366 Cr	₹191 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹1808 Cr	₹1480 Cr	₹1309 Cr	₹1086 Cr	₹1125 Cr	₹972 Cr	₹741 Cr	₹685 Cr	₹622 Cr	₹506 Cr	₹505 Cr	₹513 Cr	₹169 Cr	₹153 Cr	₹109 Cr	₹82 Cr
₹1094 Cr	₹547 Cr	₹855 Cr	₹712 Cr	₹649 Cr	₹972 Cr	₹715 Cr	₹640 Cr	₹698 Cr	₹645 Cr	₹518 Cr	₹391 Cr	₹192 Cr	₹139 Cr	₹126 Cr	₹90 Cr
₹795 Cr	₹475 Cr	₹947 Cr	₹1132 Cr	₹1085 Cr	₹1253 Cr	₹1271 Cr	₹1087 Cr	₹763 Cr	₹470 Cr	₹379 Cr	₹334 Cr	₹109 Cr	₹158 Cr	₹174 Cr	₹99 Cr
₹215 Cr	₹167 Cr	₹99 Cr	₹89 Cr	₹106 Cr	₹211 Cr	₹193 Cr	₹130 Cr	₹254 Cr	₹195 Cr	₹328 Cr	₹170 Cr	₹21 Cr	₹29 Cr	₹49 Cr	₹36 Cr
₹3912 Cr	₹2668 Cr	₹3210 Cr	₹3019 Cr	₹2965 Cr	₹3408 Cr	₹2920 Cr	₹2543 Cr	₹2336 Cr	₹1817 Cr	₹1731 Cr	₹1408 Cr	₹491 Cr	₹479 Cr	₹459 Cr	₹308 Cr
₹9473 Cr	₹8122 Cr	₹7709 Cr	₹6573 Cr	₹5947 Cr	₹6659 Cr	₹5803 Cr	₹5440 Cr	₹5089 Cr	₹4592 Cr	₹4241 Cr	₹2957 Cr	₹1394 Cr	₹1151 Cr	₹1018 Cr	₹836 Cr
₹259 Cr	₹394 Cr	₹286 Cr	₹97 Cr	₹12 Cr	₹13 Cr	₹14 Cr	₹13 Cr	₹16 Cr	₹20 Cr	₹17 Cr	₹22 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr
₹1204 Cr	₹732 Cr	₹2072 Cr	₹2182 Cr	₹2077 Cr	₹2310 Cr	₹2170 Cr	₹2128 Cr	₹1988 Cr	₹1815 Cr	₹1567 Cr	₹992 Cr	₹526 Cr	₹410 Cr	₹416 Cr	₹303 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹6005 Cr	₹5438 Cr	₹5092 Cr	₹3802 Cr	₹3472 Cr	₹3932 Cr	₹3561 Cr	₹3105 Cr	₹2635 Cr	₹2317 Cr	₹2020 Cr	₹1896 Cr	₹848 Cr	₹632 Cr	₹538 Cr	₹432 Cr
₹2686 Cr	₹2241 Cr	₹1968 Cr	₹1656 Cr	₹1428 Cr	₹1476 Cr	₹1179 Cr	₹857 Cr	₹586 Cr	₹376 Cr	₹167 Cr	₹767 Cr	₹193 Cr	₹140 Cr	₹99 Cr	₹64 Cr
₹0	₹0	₹0	₹0	₹0	₹44 Cr	₹0	₹93 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹3319 Cr	₹3197 Cr	₹3125 Cr	₹2147 Cr	₹2044 Cr	₹2412 Cr	₹2382 Cr	₹2247 Cr	₹2049 Cr	₹1941 Cr	₹1853 Cr	₹1129 Cr	₹655 Cr	₹492 Cr	₹438 Cr	₹368 Cr
₹172 Cr	₹124 Cr	₹132 Cr	₹404 Cr	₹310 Cr	₹222 Cr	₹332 Cr	₹422 Cr	₹494 Cr	₹385 Cr	₹98 Cr	₹78 Cr	₹57 Cr	₹149 Cr	₹161 Cr	₹60 Cr
₹20 Cr	₹19 Cr	₹18 Cr	₹25 Cr	₹25 Cr	₹30,000	₹30,000	₹40,000	₹10,000	₹32 L	₹32 L	₹40,000	₹3 L	₹3 L	₹3 L	₹53 L
₹20 Cr	₹19 Cr	₹18 Cr	₹25 Cr	₹25 Cr	₹30,000	₹30,000	₹40,000	₹10,000	₹32 L	₹32 L	₹40,000	₹3 L	₹3 L	₹3 L	₹53 L
₹236 Cr	₹161 Cr	₹144 Cr	₹114 Cr	₹112 Cr	₹219 Cr	₹220 Cr	₹110 Cr	₹125 Cr	₹166 Cr	₹103 Cr	₹168 Cr	₹58 Cr	₹40 Cr	₹32 Cr	₹67 Cr
₹14 Cr	₹12 Cr	₹4 Cr	₹40 Cr	₹22 Cr	₹9 Cr	₹14 Cr	₹50 Cr	₹48 Cr	₹40 Cr	₹13 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr
₹3861 Cr	₹3566 Cr	₹3449 Cr	₹2737 Cr	₹2523 Cr	₹2942 Cr	₹3100 Cr	₹2987 Cr	₹2753 Cr	₹2587 Cr	₹2131 Cr	₹1401 Cr	₹858 Cr	₹733 Cr	₹669 Cr	₹514 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹76 Cr	₹300 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹50 L	₹0
₹2398 Cr	₹1932 Cr	₹1525 Cr	₹1383 Cr	₹1449 Cr	₹1514 Cr	₹1173 Cr	₹1128 Cr	₹928 Cr	₹995 Cr	₹912 Cr	₹626 Cr	₹206 Cr	₹169 Cr	₹125 Cr	₹136 Cr
₹2563 Cr	₹2002 Cr	₹1859 Cr	₹1648 Cr	₹1309 Cr	₹1475 Cr	₹1145 Cr	₹972 Cr	₹870 Cr	₹642 Cr	₹752 Cr	₹608 Cr	₹249 Cr	₹183 Cr	₹173 Cr	₹142 Cr
₹148 Cr	₹165 Cr	₹232 Cr	₹458 Cr	₹313 Cr	₹524 Cr	₹164 Cr	₹104 Cr	₹270 Cr	₹263 Cr	₹313 Cr	₹217 Cr	₹21 Cr	₹21 Cr	₹10 Cr	₹6 Cr
₹105 Cr	₹85 Cr	₹99 Cr	₹79 Cr	₹86 Cr	₹34 Cr	₹34 Cr	₹40 Cr	₹46 Cr	₹19 Cr	₹31 Cr	₹12 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹2 Cr
₹399 Cr	₹295 Cr	₹239 Cr	₹268 Cr	₹267 Cr	₹170 Cr	₹187 Cr	₹208 Cr	₹220 Cr	₹85 Cr	₹102 Cr	₹93 Cr	₹56 Cr	₹41 Cr	₹37 Cr	₹36 Cr
₹5612 Cr	₹4556 Cr	₹4254 Cr	₹3836 Cr	₹3424 Cr	₹3717 Cr	₹2703 Cr	₹2453 Cr	₹2335 Cr	₹2005 Cr	₹2110 Cr	₹1555 Cr	₹536 Cr	₹418 Cr	₹349 Cr	₹322 Cr
₹1700 Cr	₹1888 Cr	₹1044 Cr	₹817 Cr	₹459 Cr	₹309 Cr	-₹217 Cr	-₹90 Cr	-₹94 L	₹188 Cr	₹379 Cr	₹147 Cr	₹45 Cr	-₹61 Cr	-₹110 Cr	₹14 Cr
₹9473 Cr	₹8122 Cr	₹7709 Cr	₹6573 Cr	₹5947 Cr	₹6659 Cr	₹5803 Cr	₹5440 Cr	₹5089 Cr	₹4592 Cr	₹4241 Cr	₹2957 Cr	₹1394 Cr	₹1151 Cr	₹1018 Cr	₹836 Cr
₹260	₹234	₹162	₹137	₹109	₹125	₹104	₹101	₹93	₹86	₹76	₹212	₹124	₹113	₹54	₹101
₹260	₹234	₹162	₹137	₹109	₹125	₹104	₹101	₹93	₹86	₹76	₹53	₹31	₹28	₹14	₹25

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹1287 Cr	₹971 Cr	₹727 Cr	₹747 Cr	₹973 Cr	₹657 Cr	₹105 Cr	₹331 Cr	₹290 Cr	₹296 Cr	₹770 Cr	₹370 Cr	₹119 Cr	₹290 Cr	-₹218 Cr	-₹2 Cr
₹555 Cr	₹552 Cr	₹543 Cr	₹492 Cr	₹399 Cr	₹582 Cr	₹611 Cr	₹397 Cr	₹411 Cr	₹392 Cr	₹290 Cr	₹505 Cr	₹116 Cr	-₹71 Cr	₹367 Cr	₹72 Cr
-₹530 Cr	-₹424 Cr	₹51 Cr	-₹292 Cr	-₹292 Cr	-₹335 Cr	-₹124 Cr	-₹149 Cr	-₹166 Cr	-₹94 Cr	-₹331 Cr	-₹180 Cr	-₹103 Cr	-₹47 Cr	-₹16 Cr	₹7 Cr
₹1312 Cr	₹1099 Cr	₹1321 Cr	₹947 Cr	₹1079 Cr	₹905 Cr	₹592 Cr	₹579 Cr	₹535 Cr	₹593 Cr	₹729 Cr	₹696 Cr	₹132 Cr	₹172 Cr	₹134 Cr	₹77 Cr
₹944 Cr	₹852 Cr	₹1097 Cr	₹747 Cr	₹768 Cr	₹704 Cr	₹500 Cr	₹444 Cr	₹482 Cr	₹460 Cr	₹436 Cr	₹523 Cr	₹108 Cr	₹149 Cr	₹123 Cr	₹55 Cr
-₹1193 Cr	-₹94 Cr	-₹713 Cr	-₹468 Cr	-₹789 Cr	-₹252 Cr	-₹164 Cr	-₹409 Cr	-₹426 Cr	-₹616 Cr	-₹689 Cr	-₹431 Cr	-₹168 Cr	-₹106 Cr	-₹170 Cr	-₹101 Cr
₹343 Cr	-₹814 Cr	-₹164 Cr	-₹145 Cr	-₹152 Cr	-₹189 Cr	-₹301 Cr	-₹735 Cr	-₹69 Cr	₹293 Cr	₹303 Cr	-₹250 Cr	₹57 Cr	-₹30 Cr	₹52 Cr	₹18 Cr
₹94 Cr	-₹56 Cr	₹221 Cr	₹134 Cr	-₹172 Cr	₹264 Cr	₹36 Cr	-₹699 Cr	-₹13 Cr	₹137 Cr	₹51 Cr	-₹158 Cr	-₹3 Cr	₹12 Cr	₹5 Cr	-₹29 Cr
-₹14 Cr	₹44 Cr	-₹175 Cr	-₹308 Cr	-₹350 Cr	-₹609 Cr	-₹641 Cr	₹59 Cr	₹71 Cr	-₹66 Cr	-₹129 Cr	₹344 Cr	₹21 Cr	₹9 Cr	₹3 Cr	₹32 Cr
₹0	₹0	₹0	₹0	₹214 Cr	₹0	₹0	₹0	₹0	₹0	₹13 Cr	₹18 Cr	₹0	₹0	₹0	₹0
₹18 Cr	-₹2 Cr	-₹2 Cr	-₹13 L	₹19 L	-₹5 Cr	-₹4 Cr	-₹14 L	₹3 L	-₹47 L	₹0	₹0	₹0	₹0	₹0	₹0
₹98 Cr	-₹14 Cr	₹44 Cr	-₹175 Cr	-₹308 Cr	-₹350 Cr	-₹609 Cr	-₹641 Cr	₹59 Cr	₹71 Cr	-₹66 Cr	₹204 Cr	₹18 Cr	₹21 Cr	₹9 Cr	₹3 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Emcure Pharmaceuticals Share Price

2174.20+197.60 (+10.00%)

+63.97% past 1 Year

Shareholding summary

Promoters

77.82%

FII

4.94%

DII

1.44%

7.05%

Others

8.75%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
77.82%	77.83%	77.87%	77.87%	77.88%	77.91%
4.94%	4.87%	3.35%	3.59%	3.29%	2.86%
1.44%	1.59%	1.16%	1.27%	0.78%	0.50%
7.05%	6.87%	4.94%	4.83%	3.58%	2.34%
8.75%	8.84%	12.68%	12.44%	14.47%	16.39%

Bulk & block deals

Name

Bc Investments Iv Limited

Axis Mutual Fund

Goldman Sachs Investments Mauritius I Limited

Hdfc Standard Life Insurnace

Hsbc Mutual Fund

Morgan Stanley Asia Singapore Pte

Aditya Birla Sun Life Mutual Fund

Hdfc Standard Life Insurance Company Ltd

Bnp Paribas Financial Markets

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
25 Jun 2026	Sell	176.20 Cr	₹1,817	9.70 L	Bulk	0.511245	NSE
25 Jun 2026	Sell	176.20 Cr	₹1,817	9.70 L	Bulk	0.511244	NSE
25 Jun 2026	Purchase	25 Cr	₹1,817	1.38 L	Block	0.072538	NSE
25 Jun 2026	Purchase	25 Cr	₹1,817	1.38 L	Block	0.072538	NSE
25 Jun 2026	Purchase	28.70 Cr	₹1,817	1.58 L	Block	0.083271	NSE
25 Jun 2026	Purchase	25 Cr	₹1,817	1.38 L	Block	0.072538	NSE
25 Jun 2026	Purchase	25 Cr	₹1,817	1.38 L	Block	0.072538	NSE
25 Jun 2026	Purchase	47.50 Cr	₹1,817	2.61 L	Block	0.137822	NSE
25 Jun 2026	Purchase	101.20 Cr	₹1,817	5.57 L	Block	0.293628	NSE
25 Jun 2026	Purchase	25 Cr	₹1,817	1.38 L	Block	0.072539	NSE

Insider trading & SAST

Client name

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type

Emcure Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Emcure Pharmaceuticals Share Price

Emcure Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Emcure Pharmaceuticals Share Price

Emcure Pharmaceuticals Share Price

Oscillators

Moving averages

Emcure Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Emcure Pharmaceuticals Share Price

Corporate Actions

Company details

Emcure Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Emcure Pharmaceuticals Share Price

News

Emcure Q2 EBITDA rises sharply while margin remains broadly stable

Emcure Pharmaceuticals Reports Strong Second Quarter Revenue Growth

Emcure Pharmaceuticals Reports Strong Second Quarter Consolidated Profit Growth

Emcure Pharmaceuticals Reports Rs 28.98 Crores NSE Block Trade

Emcure Pharmaceuticals sees Rs 17.47 crores NSE block trade in 90,289 shares

Emcure Pharmaceuticals to host analyst and investor meeting on September 4

Emcure Pharma gets Buy call, target raised to Rs 2,300

Jefferies maintains buy on Emcure Pharma, raises FY27 to FY29 earnings outlook

Emcure Pharma Q1 EBITDA rises with improved operating margin performance

Emcure Pharma reports Q1 revenue growth to Rs 2,600 crores

Emcure Pharma Q1 profit rises sharply on strong year-on-year growth

Emcure Pharma gets ICMR anti-HPV technology licence, expanding oncology pipeline

CDSCO clears Wegovy for fatty liver disease, boosting Emcure’s GLP-1 portfolio

Emcure Pharmaceuticals schedules Q1 earnings conference call for investor interaction

Emcure Pharmaceuticals to review first quarter results on August 6

Emcure Pharma secures full control of Gennova via remaining 12.05% stake buy

Emcure Pharma to fully acquire Gennova Biopharmaceuticals via remaining stake purchase

Emcure Pharma arm to acquire remaining stake in Canada’s Mantra Pharma

Jefferies raises Emcure Pharmaceuticals target on growth outlook

Emcure Pharma sees NSE block trade worth Rs 26.65 crores in equity

Emcure Pharmaceuticals Ltd Share Price Today

Emcure Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator